67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details

臨床試験数 : 216 / 薬物数 : 219 - (DrugBank : 50) / 標的遺伝子数 : 39 - 標的パスウェイ数 : 151

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04284657 (ClinicalTrials.gov)	January 30, 2019	11/4/2019	Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease	Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease	Autosomal Dominant Polycystic Kidney Disease	Drug: Pravastatin;Drug: sodium citrate	University of Southern California	NULL	Enrolling by invitation	18 Years	N/A	All	30	Phase 2	United States
2	NCT03273413 (ClinicalTrials.gov)	August 31, 2017	1/9/2017	Statin Therapy in Patients With Early Stage ADPKD	Statin Therapy in Patients With Early Stage ADPKD	ADPKD;Autosomal Dominant Polycystic Kidney	Drug: Pravastatin;Drug: Placebo	University of Colorado, Denver	NULL	Recruiting	25 Years	60 Years	All	200	Phase 4	United States
3	NCT00456365 (ClinicalTrials.gov)	November 2006	12/3/2007	Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease	Polycystic Kidney, Autosomal Dominant	Drug: pravastatin;Drug: Placebo	University of Colorado, Denver	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	8 Years	22 Years	All	110	Phase 3	United States